Where did Harvoni therapy enter the picture? I thought original ESRX deal gave exclusivity to V-P in preferred formulary as opposed to Sovaldi…No, the payers' decision for the GT1 patient pool is V-Pak vs Harvoni. Sovaldi is essentially an obsolete product for GT1 patients.